Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The adoption of LI-RADS: a survey of non-academic radiologists.
Marks RM, Fung A, Cruite I, Blevins K, Lalani T, Horvat N, Protopapas Z, Chaudhry H, Bijan B, Shiehmorteza M, Nepal P, Tang A. Marks RM, et al. Among authors: lalani t. Abdom Radiol (NY). 2023 Aug;48(8):2514-2524. doi: 10.1007/s00261-023-03951-9. Epub 2023 May 26. Abdom Radiol (NY). 2023. PMID: 37233747
Comparison of neuraminidase inhibiting antibody responses elicited by egg- and cell-derived influenza vaccines.
Alvarado-Facundo E, Herrup R, Wang W, Colombo RE, Collins L, Ganesan A, Hrncir D, Lalani T, Markelz AE, Maves RC, McClenathan B, Mende K, Richard SA, Schmidt K, Schofield C, Seshadri S, Spooner C, Coles CL, Burgess TH, Weiss CD, Eichelberger M. Alvarado-Facundo E, et al. Among authors: lalani t. Vaccine. 2025 Jan 3;46:126669. doi: 10.1016/j.vaccine.2024.126669. Online ahead of print. Vaccine. 2025. PMID: 39754936 Free article.
Estimating the Effect of Coronavirus Disease 2019 (COVID-19) Vaccination and Infection Variant on Post-COVID-19 Venous Thrombosis or Embolism Risk.
O'Carroll A, Richard SA, Byrne C, Rusiecki J, Wier B, Berjohn CM, Fries AC, Lalani T, Smith AG, Mody RM, Ganesan A, Huprikar N, Colombo RE, Schofield C, Lindholm DA, Mende K, Jones MU, Flanagan R, Larson DT, Ewers EC, Saunders D, Maves RC, Maldonado CJ, Sanchez Edwards M, O'Connell RJ, Simons MP, Tribble DR, Agan BK, Burgess TH, Pollett SD. O'Carroll A, et al. Among authors: lalani t. Open Forum Infect Dis. 2024 Sep 23;11(11):ofae557. doi: 10.1093/ofid/ofae557. eCollection 2024 Nov. Open Forum Infect Dis. 2024. PMID: 39494453 Free PMC article.
SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification.
Dearlove BL, Fries AC, Epsi NJ, Richard SA, Ganesan A, Huprikar N, Lindholm DA, Mende K, Colombo RE, Colombo C, Bai H, Larson DT, Ewers EC, Lalani T, Smith AG, Berjohn CM, Maves RC, Jones MU, Saunders D, Maldonado CJ, Mody RM, Bazan SE, Tribble DR, Burgess T, Simons MP, Agan BK, Pollett SD, Rolland M. Dearlove BL, et al. Among authors: lalani t. Virus Evol. 2024 Sep 2;10(1):veae071. doi: 10.1093/ve/veae071. eCollection 2024. Virus Evol. 2024. PMID: 39386074 Free PMC article.
Precision symptom phenotyping identifies early clinical and proteomic predictors of distinct COVID-19 sequelae.
Epsi NJ, Chenoweth JG, Blair PW, Lindholm DA, Ganesan A, Lalani T, Smith A, Mody RM, Jones MU, Colombo RE, Colombo CJ, Schofield C, Ewers EC, Larson DT, Berjohn CM, Maves RC, Fries AC, Chang D, Wyatt A, Scher AI, Byrne C, Rusiecki J, Saunders DL, Livezey J, Malloy A, Bazan S, Maldonado C, Edwards MS, Mende K, Simons MP, O'Connell RJ, Tribble DR, Agan BK, Burgess TH, Pollett SD, Richard SA. Epsi NJ, et al. Among authors: lalani t. J Infect Dis. 2024 Jun 25:jiae318. doi: 10.1093/infdis/jiae318. Online ahead of print. J Infect Dis. 2024. PMID: 38916431
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Clifford Lane H, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Sep 23;230(3):624-634. doi: 10.1093/infdis/jiae198. J Infect Dis. 2024. PMID: 38657001 Free PMC article. Clinical Trial.
180 results